ask="N/A"
ask_size="N/A"
average_daily_volume="362835"
bid="N/A"
bid_size="N/A"
book_value="14.89"
change="-0.04"
change_from_200_day_moving_average="-1.82"
change_from_50_day_moving_average="1.12"
change_from_52_week_high="-12.81"
change_From_52_week_low="17.82"
change_in_percent="-0.08%"
close="48.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24150000"
high="48.81"
high_52_weeks="60.98"
last_trade_date="2/17/2017"
last_trade_price="48.17"
last_trade_size="33411"
last_trade_time="4:00pm"
low="48.00"
low_52_weeks="30.35"
market_capitalization="1.31B"
moving_average_200_day="49.99"
moving_average_50_day="47.05"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="48.00"
pe_ratio="5.38"
peg_ratio="0.36"
percent_change_from_200_day_moving_average="-3.63%"
percent_change_from_50_day_moving_average="+2.39%"
percent_change_from_52_week_high="-21.01%"
percent_change_from_52_week_low="+58.71%"
previous_close="48.21"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.24"
price_per_sales="3.39"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.80"
stock_exchange="NMS"
symbol="FPRX"
volume="192986"
weeks_range_52="30.35 - 60.98"
